185 related articles for article (PubMed ID: 8595091)
1. Synthesis, structure and antitumor activity of new benz[d,e]isoquinoline-1,3-diones.
Braña MF; Castellano JM; Morán M; Emling F; Kluge M; Schlick E; Klebe G; Walker N
Arzneimittelforschung; 1995 Dec; 45(12):1311-8. PubMed ID: 8595091
[TBL] [Abstract][Full Text] [Related]
2. Bis-naphthalimides: a new class of antitumor agents.
Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
[TBL] [Abstract][Full Text] [Related]
3. Analogues of amonafide and azonafide with novel ring systems.
Sami SM; Dorr RT; Alberts DS; Sólyom AM; Remers WA
J Med Chem; 2000 Aug; 43(16):3067-73. PubMed ID: 10956214
[TBL] [Abstract][Full Text] [Related]
4. New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties.
Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Domínguez MT; Pozuelo JM; Abradelo C; Rey-Stolle MF; Yuste M; Báñez-Coronel M; Lacal JC
J Med Chem; 2004 Mar; 47(6):1391-9. PubMed ID: 14998328
[TBL] [Abstract][Full Text] [Related]
5. Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.
Sami SM; Dorr RT; Sólyom AM; Alberts DS; Remers WA
J Med Chem; 1995 Mar; 38(6):983-93. PubMed ID: 7699715
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activities of 6-amino amonafide derivatives.
Norton JT; Witschi MA; Luong L; Kawamura A; Ghosh S; Stack MS; Sim E; Avram MJ; Appella DH; Huang S
Anticancer Drugs; 2008 Jan; 19(1):23-36. PubMed ID: 18043127
[TBL] [Abstract][Full Text] [Related]
7. Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 Aug; 13(16):4864-70. PubMed ID: 15925513
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological properties of new benz[h]isoquinoline derivatives.
Janin YL; Carrez D; Riou JF; Bisagni E
Chem Pharm Bull (Tokyo); 1994 Apr; 42(4):892-5. PubMed ID: 8020124
[TBL] [Abstract][Full Text] [Related]
9. Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz[de,h]isoquinoline-1,3-diones.
Braña MF; Castellano JM; Perron D; Maher C; Conlon D; Bousquet PF; George J; Qian XD; Robinson SP
J Med Chem; 1997 Feb; 40(4):449-54. PubMed ID: 9046334
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles).
Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S
J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113
[TBL] [Abstract][Full Text] [Related]
11. 2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agent.
Sami SM; Dorr RT; Alberts DS; Remers WA
J Med Chem; 1993 Mar; 36(6):765-70. PubMed ID: 8459403
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs.
Antonini I; Volpini R; Dal Ben D; Lambertucci C; Cristalli G
Bioorg Med Chem; 2008 Sep; 16(18):8440-6. PubMed ID: 18774722
[TBL] [Abstract][Full Text] [Related]
13. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
[TBL] [Abstract][Full Text] [Related]
14. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II.
Zhu H; Huang M; Yang F; Chen Y; Miao ZH; Qian XH; Xu YF; Qin YX; Luo HB; Shen X; Geng MY; Cai YJ; Ding J
Mol Cancer Ther; 2007 Feb; 6(2):484-95. PubMed ID: 17308047
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 1-(2-aminophenyl)isoquinolines and the biological activity of their cis-dichloro platinum(II) complexes.
von Nussbaum F; Miller B; Wild S; Hilger CS; Schumann S; Zorbas H; Beck W; Steglich W
J Med Chem; 1999 Sep; 42(18):3478-85. PubMed ID: 10479280
[TBL] [Abstract][Full Text] [Related]
17. Solvent free, catalyst free, microwave or grinding assisted synthesis of bis-cyclic imide derivatives and their evaluation for anticancer activity.
Kumar A; Banerjee S; Roy P; Sondhi SM; Sharma A
Bioorg Med Chem Lett; 2017 Feb; 27(3):501-504. PubMed ID: 28011220
[TBL] [Abstract][Full Text] [Related]
18. 2-[2'-(Dimethylamino)ethyl]-1,2-dihydro- 3H-dibenz[de,h]isoquinoline-1,3-diones with substituents at positions 4, 8, 9, 10, and 11. Synthesis, antitumor activity, and quantitative structure-activity relationships.
Sami SM; Dorr RT; Alberts DS; Sólyom AM; Remers WA
J Med Chem; 1996 Dec; 39(25):4978-87. PubMed ID: 8960558
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of apoptotic effect of cyclic imide derivatives on murine B16F10 melanoma cells.
Machado KE; Oliveira KN; Santos-Bubniak L; Licínio MA; Nunes RJ; Santos-Silva MC
Bioorg Med Chem; 2011 Nov; 19(21):6285-91. PubMed ID: 21964182
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumor evaluation and DNA photocleaving activity of novel methylthiazonaphthalimides with aminoalkyl side chains.
Li Z; Yang Q; Qian X
Bioorg Med Chem Lett; 2005 Jun; 15(12):3143-6. PubMed ID: 15876532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
